Corporate and local contribution of Pfizer to Smoking Cessation José Aleixo Dias Medical Director – Pfizer, Portugal.

Slides:

Advertisements

Similar presentations

Ten years of the CHD NSF Professor Roger Boyle CBE National Director for Heart Disease and Stroke Department of Health.

Advertisements

Susi Farnworth Head of Youth Services, QUIT ®. Quit Because is the youth service at QUIT ®, the charity that helps people quit smoking. We help young.

Bronx BREATHES: Resources and Technical Assistance for Improved Tobacco Treatment Barbara Hart, MPA David Lounsbury, PhD Claudia Lechuga, MS Hal Strelnick,

UNIVERSITY OF MARYLAND SCHOOL OF LAW The Basis of a Comprehensive Regulatory Policy for Reduced Harm Tobacco Products David Sweanor, Adjunct Professor.

Smoking and mental health Mark Allen Specialist Health Improvement Practitioner.

Coronary Heart Disease (CHD): A Disease of Affluence.

The Spanish Quitline Network. The case study of the Catalonia Quitline Dolors Marin Tuyà Psychologist specialist in Clinical Psychology Public Health Directorate.

Smoking Cessation for Pregnancy and Beyond: Virtual Clinic Companion Slides Catherine A. Powers, EdD, LSW PACE – Tobacco Prevention and Cessation Education.

Health Disparities in Cardiovascular Disease Paula A. Johnson, MD, MPH Chief, Division of Women’s Health; Executive Director, Connors Center for Women’s.

Cardiac Rehabilitation Are you or someone you know missing the benefits of Cardiac Rehabilitation? July

December Cardiac Rehabilitation Are you or someone you know missing the benefits of Cardiac Rehabilitation?

Edward Anselm, MD Medical Director Public Health Perspectives of Accountable Care: Opportunities for Alignment.

New Pathways, New Connections: Tobacco and Behavioral Health Frances M. Harding, Director SAMHSA’s Center for Substance Abuse Prevention National Conference.

CARDIOVASCULAR DISEASE The Nature of CVD Extent and Trend of CVD Risk factors Social determinants High Risk Groups.

Evidence supporting ABC Smoking Dr John McMenamin GP Primary Care Advisor MOH Tobacco Team March 2015.

Orientation of the district level health workers for TB and Tobacco integration and training on counselling for smoking cessation Kathmandu, April 7 –

1 Progress in the development, monitoring, and implementation of tobacco dependence treatment around the world 13 March, 2013 Boston, MA.

Economics of Tobacco Use and Help-Seeking Behavior Bishwa Adhikari, Ph.D., Economist Office on Smoking and Health Centers for Disease Control and Prevention.

Tobacco Control Operational Plan Vila Vasoodaven Healthy Lifestyles Partnership Officer Directorate of Public Health, Health and Social Care Commissioning.

Nico-hosp-intro 1.1 Smoke-free hospital European Training guide Training programme designed for hospital staff to deal with smoking Version 2003 Smoke-free.

Smoking Cessation Treatment Services in the United Kingdom Hayden McRobbie Barts and The London School of Medicine University of London.

The impact of the EU accession on Croatia Public health policies on tobacco Marta Čivljak, MD, PHD Research Fellow Department of Medical Sociology and.

How Big is the Alcohol Problem Locally? Jess Mookherjee Consultant in Public Health Kent.

NHPA’s. What are they? National Health Priority Areas (NHPAs) are diseases and conditions chosen for focused attention at a national level because of.

Community Pharmacy and Its Contribution to Public Health Andrew Radley Consultant in Public Health (Pharmacy)

2011 Wellness Survey Data. 2 The 2011 Wellness Interest survey is sent out to staff by and in the SMART START Newsletter staff participated.

Number of deaths (’000s) in 1998 attributable to tobacco use WHO Region Males Females World Health Report 1999 All member states3, Africa 112.

Page 1 Author: Bokor Emőke – Anita (University of Medicine and Pharmacy Tîrgu-Mure, General Medicine, 6 th year) Supervisor: Dr. Germán - Salló Márta,

U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Center for Health Statistics 1 Monitoring Million Hearts.

Studying mortality trends: The IMPACT CHD Policy Model

Health New Zealand14 July Smokefree homes are the key to reducing adolescent smoking, and reducing parental smoking Murray Laugesen Health New Zealand.

Increasing Access to Pharmacotherapy Jonathan P. Winickoff, MD, MPH Associate Professor in Pediatrics Harvard Medical School April 26, 2013.

+ Role of Industry in Clinical Care, Research, and Education.

Prevalence of Tobacco Use. Current user: A person who has smoked once in the last 30 days Prevalence of tobacco use: The proportion of current users in.

Linda A. Bailey, JD, MHS How Regional Networks Can Support Quitlines 11/11/2011.

Date Name Location Smoking Cessation and Stress* COLLEGE OF EDUCATION AND HUMAN ECOLOGY COLLEGE OF NURSING COLLEGE OF FOOD AGRICULTURAL, AND ENVIRONMENTAL.

Tackling Obesity in NSW An LHD Perspective on integrating prevention into routine care John Wiggers Director, Population Health, Hunter New England Local.

Wellness Objectives Define wellness and list the tools necessary to follow a healthy lifestyle. Identify personal risk factors for disease onset and discuss.

SMOKE FREEE !!!!. Dangers of smoking to our health! One of the worlds leading experts said that now that smoking is banned everywhere that they could.

Enhancing Tobacco Cessation Treatment for the Medicaid Population Linda Bailey, Center for Tobacco Cessation Helen Halpin, University of California at.

Smoking in The United States Alexandra M. Lippert 1/30/13 ECO 5550 Presentation.

Strategies for integrated, population-based recruitment into telephone-based smoking cessation counseling Linda C. Lockard Senior Project Coordinator Center.

1 Maintaining downward pressure on smoking prevalence Robert West University College London All Party Parliamentary Group on Smoking September 2015.

1 University College London February 2014 Robert West Population impact of tobacco dependence treatment.

PUTTING PREVENTION FIRST Vascular Checks Dr Bill Kirkup Associate NHS Medical Director.

Laura Ridout Development Manager Smokefree south West April 16 th 2014.

Brief Intervention. Brief Intervention has a number of different definitions but usually encompasses: –assessment –provision of education, support and.

Dr Prak Piseth Raingsey Director Department of Preventive Medicine

World Health Organization

Introduction to the workshop and overview of our work together.

NON-COMMUNICABLE DISEASES – CURRENT SITUATION AND PREVENTION

Chronic respiratory diseases: burden, population and interventions,

Consortium for a Healthier Miami-Dade

The Alcohol Brief Intervention Programme –an Overview

American Cancer Society Workplace Solutions

How does teamwork improve value. Dr Nils E

Tim McAfee, M.D., M.P.H. Director, CDC Office on Smoking and Health

Ailsa Rutter, Director, Fresh: Smokefree North East

Tobacco Use Prevention Funding

Hypertension Update: How Low Shall We Go?

Fiona Caplan-Dean Pharmacy Services Development Manager UK

Role of Personal Health Behaviors

PUBLIC HEALTH RESPONSE to Prevention of Noncommunicable Diseases and Integration into PRIMARY CARE.

Alcohol and smoking reduction

Chronic Disease Challenges & Opportunities for Improvement

Our people die too soon, too often

Nurses making a difference in tobacco dependence treatment in Portugal

Increasing Investment in Prevention in Wales, The Journey So Far

Effects of Pay-for-Performance on the Quality of Primary Care in England Mean Scores for Clinical Quality at the Practice Level for Aspects of Care for.

The Heart Truth Delaware Background

Presentation transcript:

Corporate and local contribution of Pfizer to Smoking Cessation José Aleixo Dias Medical Director – Pfizer, Portugal

TOPICS Pfizer is very proud of sponsoring the European Network of Quitlines (ENQ) Partnerships in place between Pfizer and ENQ Pfizer Worldwide commitment to smoking cessation and drug development Pfizer contribution to smoking cessation in Portugal: The relevance of the problem and smoker’s behavioural patterns Education and training in smoking cessation Tobacco associated costs Think Tank: Portugal Sem Fumo Partnerships Public awareness campaigns

Partnerships in place between Pfizer and ENQ

TOPICS Partnerships in place between Pfizer and ENQ: Direct to smokers activities The eastern European program on social exclusion The smoke free awards

Pfizer Worldwide commitment to smoking cessation and drug development

6 Smoking Cessatio n

Pfizer contribution to smoking cessation in Portugal The relevance of the problem and smoker’s behavioural patterns

Direccionamos objectivos. Studies: Smoker motivation (Motivação do Fumador) © Novadir study report for Pfizer December 2006

Pfizer contribution to smoking cessation in Portugal Education and training in smoking cessation

Tobacco Law n.º 37/2007

Education and training in Smoking Cessation Tobbacco cessation consultations

Update version of Smoking Cessation Guide

Unal B et al. BMJ 2005;331:1–6. Avoidable deaths due to Coronary Heart Disease in England & Wales, attributable to risk factor changes Deixar de fumar Colesterol reduction Blood Pressure reduction 24, Smoking cessation Avoidable deaths (number) 0 Reimbursement (€) millions 99 millions

Contribution of National & International Experts April 15th, 2008 “… the nature and potential intensity of clinical effects caused by tobacco are not less than those caused by alcohol or opiates”. “Relapse from quitting back to smoking is higher with tobacco than with alcohol or other drugs”. Serena Tonstad, Professor Serena Tonstad, Professor Director of Preventive Care School of Public Health School of Public Health Loma Linda University

Pfizer contribution to smoking cessation in Portugal Tobacco associated costs

Tobacco associated costs in Portugal Conclusions: The global cost to the Health System in 2005 was estimated to be: 436 millions €uros. Income from taxation over tobacco during the same year was of 1323 millions €uros.

Pfizer contribution to smoking cessation in Portugal Think Tank: Smoke Free Portugal (Portugal Sem Fumo)

Pfizer contribution to smoking cessation in Portugal Partnerships

Partnerships: APMCG & MISSION for Primary Care Fellowship on “Good multidisciplinar collaboration in Smoking Cessation at the Primary Care level” ( Bolsa de Boas Práticas em Colaboração Multidisciplinar Cuidados de Saúde Primários)

Partnerships: Nat.Association of Pharmacies (ANF)

Pfizer contribution to smoking cessation in Portugal Public awareness campaigns

Smoke Free Day

Manual of good practices in managing smoking cessation

Public awareness campaigns